{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:55:09Z","timestamp":1782971709377,"version":"3.54.5"},"reference-count":39,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1710.110117","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T19:23:10Z","timestamp":1315941790000},"page":"1807-1815","source":"Crossref","is-referenced-by-count":26,"title":["Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009\u20132010"],"prefix":"10.3201","volume":"17","author":[{"given":"Laurence","family":"Calatayud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Lackenby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"McMenamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick F.","family":"Phin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pebody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2011,10]]},"reference":[{"key":"key-10.3201\/eid1710.110117-201208240936-R1","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1128\/AAC.47.7.2264-2272.2003","article-title":"Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.","volume":"47","author":"McKimm-Breschkin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1710.110117-201208240936-R2","unstructured":"National Institute for Health and Clinical Excellence. Influenza\u2014zanamivir, amantadine and oseltamivir (review). Amantadine, oseltamivir, and zanamivir for the treatment of influenza (review of existing guidance no. 58). NICE; Feb 2009 [cited 2011 Jun 12]. http:\/\/guidance.nice.org.uk\/TA168"},{"key":"key-10.3201\/eid1710.110117-201208240936-R3","unstructured":"Department of Health. Swine flu pandemic: from containment to treatment. Guidance for the NHS, 2 July 2009. The Organization; 2009 [cited 2011 Jun 12]. http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/documents\/digitalasset\/dh_102021.pdf"},{"key":"key-10.3201\/eid1710.110117-201208240936-R4","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1710.110117-201208240936-R5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study.","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"key-10.3201\/eid1710.110117-201208240936-R6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1086\/500465","article-title":"Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.","volume":"193","author":"Ison","year":"2006","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1710.110117-201208240936-R7","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1128\/AAC.49.11.4515-4520.2005","article-title":"Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.","volume":"49","author":"Mishin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1710.110117-201208240936-R8","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1086\/424572","article-title":"Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.","volume":"190","author":"Herlocher","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1710.110117-201208240936-R9","doi-asserted-by":"crossref","unstructured":"Ciancio BC, Meerhoff TJ, Kramarz P, Bonmarin I, Borgen K, Boucher CA, Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007\u20138 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveill. 2009;14:pii:19412.","DOI":"10.2807\/ese.14.46.19412-en"},{"key":"key-10.3201\/eid1710.110117-201208240936-R10","first-page":"433","article-title":"Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1710.110117-201208240936-R11","unstructured":"World Health Organization. Viruses resistant to oseltamivir (Tamiflu) identified. Pandemic (H1N1) 2009 briefing note 1. The Organization; 2009 [cited 2011 Jan 20]. http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_antiviral_resistance_20090708\/en"},{"key":"key-10.3201\/eid1710.110117-201208240936-R12","unstructured":"World Health Organization. Pandemic (H1N1) 2009\u2014update 98. Weekly virological surveillance update. Geneva: The Organization; 2010 [cited 2011 Jan 11]. http:\/\/www.who.int\/csr\/disease\/swineflu\/laboratory30_04_2010\/en"},{"key":"key-10.3201\/eid1710.110117-201208240936-R13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/infdis\/jiq007","article-title":"Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.","volume":"203","author":"Moore","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1710.110117-201208240936-R14","first-page":"969","article-title":"Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis\u2014North Carolina, 2009.","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1710.110117-201208240936-R15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJMc0910448","article-title":"A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.","volume":"362","author":"Mai","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1710.110117-201208240936-R16","first-page":"453","article-title":"Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009.","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid1710.110117-201208240936-R17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jcv.2009.08.004","article-title":"Detection of an oseltamivir-resistant pandemic influenza A\/H1N1 virus in Hong Kong.","volume":"46","author":"Leung","year":"2009","journal-title":"J Clin Virol"},{"key":"key-10.3201\/eid1710.110117-201208240936-R18","first-page":"893","article-title":"Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients\u2014Seattle, Washington, 2009.","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1710.110117-201208240936-R19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jcv.2010.02.019","article-title":"Oseltamivir-induced resistant pandemic A\/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.","volume":"48","author":"Esposito","year":"2010","journal-title":"J Clin Virol"},{"key":"key-10.3201\/eid1710.110117-201208240936-R20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/135965350801300602","article-title":"Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.","volume":"13","author":"Lackenby","year":"2008","journal-title":"Antivir Ther"},{"key":"key-10.3201\/eid1710.110117-201208240936-R21","first-page":"1","article-title":"Hospitalization in two waves of pandemic influenza A(H1N1) in England.","volume":"26","author":"Campbell","year":"2010","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid1710.110117-201208240936-R22","doi-asserted-by":"crossref","unstructured":"Health Protection Agency; Health Protection Scotland; National Public Health Service for Wales; HPA Northern Ireland swine influenza investigation teams. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April\u2013June 2009. Euro Surveill. 2009;14:pii:19232.","DOI":"10.2807\/ese.14.22.19232-en"},{"key":"key-10.3201\/eid1710.110117-201208240936-R23","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3201\/eid1512.091057","article-title":"Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China.","volume":"15","author":"Chen","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1710.110117-201208240936-R24","first-page":"37","article-title":"Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010.","volume":"85","author":"World Health Organization","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid1710.110117-201208240936-R25","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1017\/S0950268810001366","article-title":"Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases.","volume":"138","author":"McLean","year":"2010","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid1710.110117-201208240936-R26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1017\/S0950268807008436","article-title":"Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999\u20132005.","volume":"136","author":"Pebody","year":"2008","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid1710.110117-201208240936-R27","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April\u2013June 2009.","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1710.110117-201208240936-R28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3201\/eid1702.101724","article-title":"Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009. United States.","volume":"17","author":"Graitcer","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1710.110117-201208240936-R29","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3201\/eid1607.091691","article-title":"M. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.","volume":"16","author":"Tramontana","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1710.110117-201208240936-R30","doi-asserted-by":"crossref","unstructured":"Hurt AC, Deng YM, Ernest J, Caldwell N, Leang L, Iannello P, Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill. 2011;16:pii:19770.","DOI":"10.2807\/ese.16.03.19770-en"},{"key":"key-10.3201\/eid1710.110117-201208240936-R31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/187152611794407818","article-title":"Epidemiology, prevention, and management of influenza in patients with hematologic malignancy.","volume":"11","author":"Ison","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"key-10.3201\/eid1710.110117-201208240936-R32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.md.0000232560.22098.4e","article-title":"Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.","volume":"85","author":"Chemaly","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"key-10.3201\/eid1710.110117-201208240936-R33","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1001\/jama.2009.1583","article-title":"Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.","volume":"302","author":"Louie","year":"2009","journal-title":"JAMA"},{"key":"key-10.3201\/eid1710.110117-201208240936-R34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.1177238","article-title":"Transmission and pathogenesis of swine-origin 2009 A (H1N1) influenza viruses in ferrets and mice.","volume":"325","author":"Maines","year":"2009","journal-title":"Science"},{"key":"key-10.3201\/eid1710.110117-201208240936-R35","doi-asserted-by":"publisher","first-page":"b5213","DOI":"10.1136\/bmj.b5213","article-title":"Mortality from pandemic A\/H1N1 2009 influenza in England: public health surveillance study.","volume":"339","author":"Donaldson","year":"2009","journal-title":"BMJ"},{"key":"key-10.3201\/eid1710.110117-201208240936-R36","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa0908481","article-title":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand.","volume":"361","author":"ANZIC Influenza Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1710.110117-201208240936-R37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1503\/cmaj.091884","article-title":"Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.","volume":"182","author":"Zarychanski","year":"2010","journal-title":"CMAJ"},{"key":"key-10.3201\/eid1710.110117-201208240936-R38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00134-003-2136-x","article-title":"Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study.","volume":"30","author":"Brun-Buisson","year":"2004","journal-title":"Intensive Care Med"},{"key":"key-10.3201\/eid1710.110117-201208240936-R39","doi-asserted-by":"crossref","unstructured":"Harvala H, Gunson R, Simmonds P, Hardie A, Bennett S, Scott F, The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November\u2013December, 2009. Euro Surveill. 2010;15:pii:19536.","DOI":"10.2807\/ese.15.14.19536-en"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/17\/10\/11-0117_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:09:13Z","timestamp":1733285353000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/17\/10\/11-0117_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1710.110117","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}